Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
The practical solution Many researchers address this by reconstituting only what they need for roughly four weeks of dosing
About the research The STEP 1 trial published in the New England Journal of Medicine was a randomized, double-blind, placebo-controlled study that followed more than 1,900 adults with overweight or obesity (but without diabetes) for 68 weeks
When you lose weight quickly, your blood volume may change, and your body is in a state of metabolic transition
Safety Considerations and Who Should Start Conservatively Female patients with liver disease, severe kidney impairment, or uncontrolled thyroid dysfunction require careful dosing oversight and may need lower starting doses or extended monitoring intervals
Great for advanced research Well-formulated blend for our advanced recovery research protocols
